Searched for
DOCON TECHNOLOGIES
Thyrocare promoter sells 10% stake for Rs 667 croreDocon Technologies has divested a 10% stake in Thyrocare Technologies for a substantial Rs 667 crore, bringing its ownership down to 61%. N...
PharmEasy devaluation: Thyrocare founder invokes anti-dilution; Flipkart employees to receive esop payoutHappy Friday! Arokiaswamy Velumani, founder of Thyrocare, which was acquired by PharmEasy in 2021, had secured anti-dilution rights when he...
Healthtech startup PharmEasy lays off more employeesThe layoffs were attributed to a variety of factors, including restructuring, macroeconomic headwinds, and the ongoing Russia-Ukraine confl...
PharmEasy in talks to raise upto $300 million, valuation may drop by halfExisting investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...
Thyrocare to stay focused on volumes, on time performance & qualityThe company is investing heavily on improving turnaround time and addressing quality perception of the brand in the market through a combin...
Watch out for these factors in Thyrocare as closely as you would watch any symptoms!Through strategic acquisitions in the healthcare space, the company seems to be aiming to create “a holistic healthcare ecosystem”. From th...
AstraZeneca partners with Docon to digitalise 1,000 clinics across IndiaUnder the AstraZeneca-Docon partnership, the Bengaluru-based healthtech startup will equip the identified clinics with customised Electroni...
PharmEasy buyout puts Thyrocare in a different league: AnalystsThyrocare is making efforts to bolster its brand visibility through the opening of regional and zonal reference laboratories and branded co...
PharmEasy to acquire 66% stake in Thyrocare for over Rs 4,500 crorePharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies, in what the online pharmacy claimed was the first ever...
PharmEasy to acquire 66% stake in Thyrocare Tech, to make open offer to grab additional 26%PharmEasy claims to be India’s number one online pharmacy and diagnostics brand. Thyrocare prides itself as the largest diagnostic company.
PharmEasy to acquire ThyrocareFrom Pharmeasy-Thyrocare deal to Twitter briefly locking IT minister's account and China's role in 2021's crypto collapse, here's a quick l...
View: Healthcare will never be the same after Covid – given how fast myths were shattered and consumer behaviours transformedWe outline six common myths that were broken by the pandemic. As we look at the transformations that happened, there is a prescription for ...